U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)

[X]     Quarterly report under Section 13 or 15(d) under the Securities Exchange
        Act of 1934.

        For the quarterly period ended      June 30, 2000
                                        -------------------------

[  ]    Transition report under Section 13 or 15(d) of the Exchange Act.

        For the transition period from                     to
                                        ------------------    ------------------

                        Commission file number 000-28301
                                               ---------

                           ID TECHNOLOGIES CORPORATION
         ---------------------------------------------------------------
        (Exact Name of Small Business Issuer as Specified in Its Charter)

         North Carolina                                          56-1866233
------------------------------------                         -----------------
   (State or Other Jurisdiction of                            (I.R.S. Employer
   Incorporation or Organization)                            Identification No.)


                        920 Main Campus Drive / Suite 400
                          Raleigh, North Carolina 27606
                    -----------------------------------------
                    (Address of Principal Executive Offices)


                                 (919) 424-3722
                ------------------------------------------------
                (Issuer's Telephone Number, Including Area Code)

                                       N/A
                -------------------------------------------------
                        (Former Name, Former Address and
                Former Fiscal Year, if Changed Since Last Report)

         Check whether the issuer: (1) filed all reports required to be filed by
Section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days.

Yes      X         No
   ---------------   ---------------

         State the number of shares  outstanding of each of the issuer's classes
of common equity,  as of the latest  practicable  date: The issuer had 8,393,570
shares of common stock outstanding as of August 1, 2000.

         Transitional Small Business Disclosure Format (check one):

Yes                No      X
   ---------------   ---------------

<PAGE>

                                FORM 10-QSB INDEX

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

PART I        FINANCIAL INFORMATION
              Item 1.      Financial Statements.
              Item 2.      Management's Plan of Operation.

PART II       OTHER INFORMATION
              Item 1.      Legal Proceedings.
              Item 2.      Changes in Securities and Use of Proceeds.
              Item 3.      Defaults Upon Senior Securities.
              Item 4.      Submission of Matters to a Vote of Security Holders.
              Item 5.      Other Information.
              Item 6.      Exhibits and Reports on Form 8-K.

SIGNATURES





CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

         This Form 10-QSB contains  forward-looking  statements.  Any statements
contained in this Form 10-QSB that are not  statements  of  historical  fact are
intended to be and are hereby  identified as  forward-looking  statements within
the  meaning  of the  Private  Securities  Litigation  Reform  Act of  1995.  ID
Technologies  Corporation,  a  North  Carolina  corporation  (the  "Company"  or
"IDTEK")  cautions  readers that  forward-looking  statements  involve known and
unknown risks and uncertainties  which could cause actual results or outcomes to
differ  materially  from  those  expressed  in the  forward-looking  statements.
Forward-looking  statements  include  statements  concerning plans,  objectives,
goals,  strategies,  expectations,  future events or performance  and underlying
assumptions and other  statements  which are other than statements of historical
facts.

         Without limiting the foregoing,  words such as "may," "will," "expect,"
"believe,"  "anticipate,"  "estimate,"  "continue" or comparable terminology are
intended to  identify  forward-looking  statements.  These  statements  by their
nature  involve  substantial  risks and  uncertainties,  and actual  results may
differ  materially  depending  on a variety  of  factors,  many of which are not
within the Company's  control.  These factors  include,  but are not limited to,
economic  conditions  generally  and in the  industries in which the Company may
participate;   competition  within  the  Company's  chosen  industry,  including
competition from much larger competitors; technological advances; and failure by
the  Company  to  successfully   develop  potential   products  and/or  business
relationships and strategic alliances.  In addition to other factors and matters
discussed  elsewhere  herein,  the following are important  factors that, in the
view of the Company,  could cause actual results to differ materially from those
discussed in the  forward-looking  statements:  ability of the Company to obtain
acceptable forms and amounts of financing to fund current and future operations,
research and development and acquisitions;  competition; the Company's operating

<PAGE>

losses; the Company's ability to commercially develop its proposed products; the
Company's  ability  to  attract,   hire  and  retain  employees  and  management
personnel;  and the Company's ability to regain control over the development and
exploitation of its technology.  The Company  disclaims any intent or obligation
to  update  these  forward-looking  statements,  whether  as  a  result  of  new
information, future events or otherwise.




                          PART I FINANCIAL INFORMATION

Item 1.  Financial Statements


<PAGE>


ID Technologies Corporation
(A Development Stage Company)
Balance Sheets
                                                                    December 31,
                                                  June 30, 2000         1999
                                                   (Unaudited)        (Audited)
                                                   ------------     ------------
Assets
   Cash and cash equivalents                       $     50,785     $    62,986
   Notes receivable                                       3,270           3,270
   Prepaid expenses                                      10,930             150
                                                   ------------     ------------
          Total current assets                           64,985          66,406

   Equipment, net                                         1,508           1,884
   Patents, net                                          15,570          17,562
                                                   ------------     ------------
Total Assets                                       $     82,063     $    85,852
                                                   ============     ============

Liabilities and Shareholders' Deficit
   Accounts payable and accrued liabilities        $    142,918     $   122,260
   Earnest money from Protek                            100,000              -
   Note payable to shareholder                           50,000              -
   Convertible debt, net of discount of
      $57,000 and $171,000 at June 30,
      2000 and December 31, 1999,
      respectively                                      243,000         129,000
                                                   ------------     ------------
          Total current liabilities                     535,918         251,260

   Deferred Revenue                                      93,000          93,000
   Long term convertible debt, net
      of discount of $26,858 and $34,166
      at June 30, 2000 and December 31,
      1999, respectively                                158,142         150,834

Shareholders' deficit:
   Series A Preferred stock, $.001 par
       value; 300,000 shares authorized;
       no shares issued and outstanding                      -               -
   Common stock, no par value,
       5,000,000  shares  authorized;
       8,393,570 and 8,277,583 shares
       issued and outstanding at June
       30, 2000 and December 31, 1999,
       respectively                                     282,953         282,953
   Additional paid-in capital                         3,476,909       3,390,859
   Deficit accumulated during
      the developmental stage                        (4,464,859)     (4,083,054)
                                                   ------------     ------------
          Total shareholders' deficit                  (704,997)       (409,242)
                                                   ------------     ------------
Total liabilities and sharehholders' deficit       $     82,063     $    85,852
                                                   ============     ============
<PAGE>

ID Technologies Corporation
(A Development Stage Company)
Statements of Operations
<TABLE>
<CAPTION>

                                                                                              Period from
                                                                                          Inception (March 16,
                                            6 months ended        6 months ended             1994) through
                                            June 30, 2000          June 30, 1999             June 30, 2000
                                             (Unaudited)           (Unaudited)               (Unaudited)
                                            --------------        --------------          ---------------------
<S>                                         <C>                   <C>                     <C>
License revenue                             $        -            $        -              $             92,000
Research and development                            10,000               136,000                       673,668
Selling, general and
      administrative expenses                      226,916               193,520                     3,647,088
                                            --------------        --------------          ---------------------
         Loss from Operations                     (236,916)             (329,520)                   (4,228,756)

Other Income & Expense:
  Interest income - contractual                      -                     1,000                         2,157
  Amortization of debt discount on
        convertible debentures                    (121,308)               (2,396)                     (188,012)
  Interest expense                                 (23,581)               (3,554)                      (50,248)
                                            --------------        --------------          ---------------------
                                                  (144,889)               (4,950)                     (236,103)
                                            --------------        --------------          ---------------------
Net Loss                                    $     (381,805)       $     (334,470)         $         (4,464,859)
                                            ==============        ==============          =====================

Basic and diluted per common share          $        (0.05)       $        (0.04)
                                            ==============        ==============

Weighted average number
     of common shares                            8,335,869             8,176,181
                                            ==============        ==============

</TABLE>



                                            3 months ended        3 months ended
                                            June 30, 2000         June 30, 1999
                                               (Unaudited)          (Unaudited)
                                            --------------        --------------

License revenue                             $        -            $       -
Research and development                             -                   68,000
Selling, general and
      administrative expenses                      142,602              155,613
                                            --------------        --------------
         Loss from Operations                     (142,602)            (223,613)

Other Income & Expense:
  Interest income - contractual                      -                    1,000
  Amortization of debt discount on
      convertible debentures                       (60,654)              (2,396)
  Interest expense                                 (11,900)              (1,444)
                                            --------------        --------------
                                                   (72,554)              (2,840)
                                            --------------        --------------
Net Loss                                    $     (215,156)       $    (226,453)
                                            ==============        ==============

Basic and diluted per common share          $        (0.03)       $       (0.03)
                                            ==============        ==============

Weighted average number
      of common shares                           8,393,570             8,176,529
                                            ==============        ==============

<PAGE>

ID Technologies Corporation
(A Development Stage Company)
Statement of Shareholders' Equity (Deficit)
Period from inception (March 16, 1994) through June 30, 2000
<TABLE>
<CAPTION>

                                                                                Deficit
                                                                Additional    Accumulated
                                                                 Paid-in        During
                                     Shares           Amount      Capital      Development      Total
                                   -----------    -----------   ----------    ------------   -----------
<S>                                <C>            <C>           <C>           <C>            <C>

Balance at March 16, 1994                 -       $     -             -        $      -      $     -
Issuance of common shares
   for cash and noncash
   consideration                     1,595,200            366           33            -              399
Net loss                                  -             -             -               (123)         (123)
                                   -----------    -----------   ----------      ----------   ------------

Balance at December 31, 1994         1,595,200            366           33            (123)          276
Issuance of common shares
   for cash and noncash
   consideration                       404,800          -              101            -              101
Net loss                                  -             -             -             (2,263)       (2,263)
                                   -----------    -----------   ----------      ----------   ------------

Balance at December 31, 1995         2,000,000            366          134          (2,386)       (1,886)

Issuance of common shares
   for cash and noncash
   consideration                     6,000,000    $     -       $    1,500     $      -      $     1,500
Net loss                                  -             -             -            (29,889)      (29,889)
                                   -----------    -----------   ----------     -----------   ------------

Balance at December  31, 1996        8,000,000            366        1,634         (32,275)      (30,275)
Issuance of common shares
   for cash, net of
   issuance costs                      153,333        282,587         -               -          282,587
Capital contribution in form
   of research and
   development services                   -             -          201,405            -          201,405
Stock based compensation                  -             -        1,333,600            -        1,333,600
Net loss                                  -             -             -         (1,684,313)   (1,684,313)
                                   -----------    -----------   ----------     -----------   -----------

Balance at December  31, 1997        8,153,333        282,953    1,536,639      (1,716,588)      103,004
Issuance of common shares
   for cash, net of
   issuance costs                       22,500          -           45,000            -           45,000
Capital contribution in form
   of research and
   development services                   -             -          192,319            -          192,319
Stock based compensation                  -             -          933,425            -          933,425
Net loss                                  -             -                -      (1,426,725)   (1,426,725)
                                   -----------    -----------   ----------     -----------   ------------

Balance at December 31, 1998         8,175,833        282,953    2,707,383      (3,143,313)     (152,977)


Issuance of warrants in connection
   with convertible debt                  -             -          271,870            -          271,870
Capital contribution in form
   of research and
   development services                   -             -          269,441            -          269,441
Issuance of common shares
   for noncash consideration           101,750          -          142,165            -          142,165
Net loss                                  -             -             -           (939,741)     (939,741)
                                   -----------    -----------   ----------     -----------   ------------

Balance at December 31, 1999         8,277,583        282,953    3,390,859      (4,083,054)     (409,242)
Capital contribution in form
   of research and
   development services                   -             -           10,000            -           10,000
Issuance of common shares
   for noncash consideration           115,987          -           76,050            -           76,050
Net loss                                  -             -             -           (381,805)     (381,805)
                                   -----------    -----------   ----------     -----------   ------------

Balance at June 30, 2000             8,393,570    $   282,953   $3,476,909     $(4,464,859)  $  (704,997)
                                   ===========    ===========   ==========     ===========   ============
</TABLE>



<PAGE>



ID Technologies Corporation
(A Development Stage Company)
Statements of Cash Flows

<TABLE>
<CAPTION>

                                                                                    Period from
                                                                                     Inception
                                                                                    (March 16,
                                                  6 months ended   6 months ended  1994) through
                                                   June 30, 2000   June 30, 1999   June 30, 2000
                                                    (Unaudited)      (Unaudited)    (Unaudited)
                                                   -------------   -------------   -------------
<S>                                               <C>              <C>             <C>

Cash flows from operating activities:
Net loss                                           $    (381,805)  $    (334,470)  $  (4,464,859)
Adjustments to reconcile net loss to
  net cash used in operating activities:
    Depreciation                                             376             246           1,767
    Amortization                                           1,992           1,993          12,333
    Deferred revenue                                        -              -              93,000
    Stock based compensation                                -              -           2,267,025
    Noncash marketing expenses                              -              4,165          49,165
    Noncash development expenses                          10,000         136,000         674,794
    Noncash professional fees                             76,050           -             214,050
    Discount on convertible debentures                   121,308           2,396         188,012
    Change in operating assets and liabilities:
          Notes receivable                                  -             10,000          (3,270)
          Prepaids and Deposits                          (10,780)          -             (10,930)
          Accounts payable and accrued liabilities        20,658         (29,664)        142,918
                                                   -------------   -------------   -------------

Net cash used in operating activities                   (162,201)       (209,334)       (835,995)


Cash flows from investing activities:
   Patent costs                                             -              -             (27,903)
   Purchase of equipment                                    -              -              (3,275)
                                                   -------------   -------------   -------------

Net cash used in investing activities                       -              -             (31,178)

Cash flows from financing activities:
   Proceeds from note payable to shareholder             100,000          20,000         202,750
   Payment of note payable to shareholder                (50,000)        (57,290)       (152,750)
   Proceeds from Earnest Money-Protek                    100,000                         100,000
   Proceeds from sale of debentures                         -            265,000         565,000
   Payment on convertible debt                              -              -             (80,000)
   Proceeds from issues of common shares, net               -              -             282,958
                                                   -------------   -------------   -------------

Net cash provided by financing activities                150,000         227,710         917,958
                                                   -------------   -------------   -------------
Increase in cash and cash equivalents                    (12,201)         18,376          50,785

Cash and cash equivalents, beginning of period            62,986           8,254           -
                                                   -------------   -------------   -------------
Cash and cash equivalents, end of period           $      50,785   $      26,630   $      50,785
                                                   =============   =============   =============


</TABLE>
<PAGE>


ID Technologies Corporation
(A Development Stage Company)
Notes to Financial Statements
June 30, 2000
(Unaudited)

1.  Management's Opinion
These  financial  statements  should  be read in  conjunction  with the  audited
consolidated  financial  statements and notes thereto  included in the Company's
Form 10-KSB for the fiscal year ended December 31, 1999.

2.  Debt Discount Amortization
Substantially all of the debt discount amortization expense is a non-cash charge
to account for the value of the stock  warrants  granted to  Centennial  Venture
Partners ("CVP") in conjunction with the $300,000 convertible  debentures issued
in September  1999.  The warrants must be expensed over the one-year life of the
debt,  which is due September  2000. The remaining debt discount of $57,000 will
be amortized in the third quarter of fiscal year 2000.

Without the debt  discount  amortization,  the net loss for the six months ended
June 30,  2000 would be  $260,497,  as compared  to a net loss of  $381,805,  as
reported.

3.       Good Faith Deposit from Protective Technologies, Inc.
On May 2, 2000,  the Board of  Directors  announced  agreement  in  principal to
purchase Protective  Technologies  Incorporated  (Protek).  This acquisition was
subject to, among other things, successful negotiation, due diligence and Protek
Board  approval.  In  conjunction  with the potential  acquisition,  the Company
received  a  good  faith  deposit  of  $100,000  from  Protek.   There  were  no
restrictions  placed on the use of this  deposit nor was any  written  agreement
signed with respect to the deposit.  The Company believes that the understanding
was that if the acquisition  did not occur due to the fault of the Company,  the
Company  would be required to repay the  deposit to Protek.  Protek  declined to
complete the  transaction  on August 2, 2000.  Since the Company  stood ready to
complete the acquisition, the Company believes that it is entitled to retain the
$100,000.

4.       Interest Payable
The  convertible  debentures  issued  April  through  June of  1999  carry a 12%
interest which accrues  monthly.  The first interest  payment was due June 2000.
The debenture  holders have received a written request to convert their interest
receivable  into common  shares of the Company at current  fair market  value of
$0.60 per share. The interest is properly  accrued,  but not yet paid in cash or
stock as the holders have not yet responded.

5.       Shareholders' Equity (Deficit)
In March and April 2000,  the Company  issued  115,987  shares of common  stock,
valued at $76,050, in exchange for professional  services.

<PAGE>
Item 2.  Management's Plan of Operation

         The Company is engaged in the  development  of biometric  technologies,
know-how, and products for licensing worldwide. The Company holds the patent for
a card,  panel,  or substrate  allowing  "on-board"  storage and  authentication
(identification) of fingerprints with a frontier biometric market size estimated
to be 1/10 trillion  dollars.  The  applications of this technology are many and
varied: from welfare cards to loyalty/medical records/personal information cards
to controlling firearms by one user.

         The  development  and  production  of this  biometric  breakthrough  is
managed by the Company's scientific partner,  Information  Resources Engineering
("IRE")  of  Baltimore,  Maryland.  IRE is a leading  provider  of  network  and
internet security systems and technologies. IRE is a shareholder of the Company,
owning 13.7% of the Company's outstanding common stock. IRE also holds a Company
license  with rights to the  internet,  computer  network,  banking and treasury
fields worldwide.

         A prototype  card was completed at the end of the Company's 1999 fiscal
year,  as well as a  comprehensive  manufacturing  plan to  build a  single-chip
production card at a cost below $20. The  non-recurring  engineering  cost (NRE)
will be paid by IRE to the production card maker at a cost of approximately $1.7
million.

         Presently,  the Company has initial licenses in place with IRE, Protek,
Power^Up Marketing Corporation, BrentScott Associates and Revolution Labs, which
are  expected to yield one  million  dollars in initial  license  fees when card
production begins. Production is expected to begin in 2001.

         The Company believes it has to be the  first-to-market  leader with the
following competitive advantages:

o    A  biometric  fingerprint  card with  storage and a power  source  (lithium
     battery) on board.
o    A biometric fingerprint card not requiring an independent power source.
o    A biometric  fingerprint card safe-guarding  personal privacy (a government
     or corporate-based database system is unnecessary).
o    A biometric  fingerprint  card with 113 m.p.s of computing power (the power
     of a Palm Pilot).

The biometric  fingerprint  card is essentially a standalone  computer on a card
protected by the Lane foundation  patent:  United States Patent Number 5,623,552
issued on April 22, 1997.

         The  Company  has  been  a  developmental-stage  company  with  nominal
revenues since its inception.  Losses were $1,426,725 in 1998, $939,741 in 1999,
$334,470 in the six months  ended June 30,  1999 and  $381,805 in the six months
ended June 30, 2000.

         As of June 2000,  the  Company had  depleted  its cash.  The  Company's
Chairman lent the Company $50,000 in June 2000 to support the Company's  working
capital  needs.  The  Company  is trying to raise at least  $1.5  million in the
immediate future with $500,000 of that needed for current year operations.
<PAGE>

         With  the  Company's   policy  of  contracting   out   development  and
concentrating  on licensing of its intellectual  property,  the Company does not
plan to  purchase  any  equipment  or buy or rent  plant(s)  in the  next  year.
Nonetheless, when and if the $1.5 million is raised, the Company intends to hire
a high-level engineer to oversee the Company's  multi-development  card projects
and assist the Company's licensees with their particular biometric applications.

         Results of Operations

         The following  discussion provides an analysis of the Company's results
of  operations  and  liquidity  and  capital  resources.  This should be read in
conjunction with the financial  statements of the Company and notes thereto. The
operating results of the periods  presented were not  significantly  affected by
inflation.

         Comparison of Six Months Ended June 30, 2000 and 1999:

         There was no license or royalty  revenue for the six months  ended June
30, 2000 or 1999.  License fee payments are  predicated  primarily on a $20 cost
biometric  fingerprint  production card.  Royalty payments are predicated on the
sale of the cards to end-users by licensees.

         The research  and  development  expenses  are a non-cash  entry in both
periods,  which mirrors exactly IRE's research and development cash expenses for
the  development  of  the  biometric   fingerprint   card.  IRE's  research  and
development cost for the card was $10,000 for the six months ended June 30, 2000
compared to $136,000 for the six months  ended June 30,  1999.  Even though IRE,
the Company's development partner and 13.7% shareholder,  is responsible for and
incurred this expense, ID Technologies must record the expense since the Company
receives the benefits from IRE's research.

         Selling,  general,  and  administrative  expenses during the six months
ended June 30, 2000 were $226,916,  up 17% from the $193,520 of such expenses in
the prior year period due to an increase in legal fees with the  acquisition  of
Protective Technologies which is now cancelled.

         Amortization of debt discount on convertible debentures was $121,308 in
the first six months of 2000  compared  to $2,396 in the first six months of the
1999 fiscal  year.  This is a non-cash  expense to amortize the value of options
and warrants associated with the $485,000 of convertible debt obtained in 1999.

         Interest  expense was $23,581 in the first six months of 2000,  up from
the $3,554 recorded in the first six months of 1999. This represents the accrued
interest of 12% on $185,000  convertible  debentures  issued in mid-1999  and 8%
interest on $300,000  convertible  debentures issued in September 1999. The only
debt  outstanding  in the  first  six  months  of 1999 was a small  note  from a
shareholder.

         The Company's net operating loss for the six months ended June 30, 2000
was  $236,916,  down 28% from the net  operating  loss of  $329,520  for the six
months ended June 30, 1999.  The Company is delaying the  necessary  development
and marketing  expenditures until they close on additional financing or complete
an acquisition that will provide working capital.
<PAGE>

                            PART II OTHER INFORMATION

Item 1.  Legal Proceedings.

         The Company is not involved in any material  pending  legal  proceeding
adverse to the Company.

Item 2.       Changes in Securities and Use of Proceeds.

         There  were no sales of common  stock in the second  quarter;  however,
there were 115,987 shares issued in exchange for professional services.  111,399
of these shares were issued to the Company's law firm in payment of certain past
due amounts and for certain  future  legal  services.  The balance of the shares
were issued to an outside  accounting  firm and an executive  search  firm.  The
Company  relied on Section  4(2) of the  Securities  Act of 1933,  as amended in
connection  with  these  issuances  based on the  preexisting  relationship  the
Company  had  with  these   service   providers   and  the  service   providers'
sophistication and financial wherewithal.

Item 3.       Defaults Upon Senior Securities.

         None.

Item 4.  Submission of Matters to a Vote of Security Holders.

         No matters  were  submitted  to a vote of security  holders  during the
quarter ended June 30, 2000.

Item 5.       Other Information.

         None.

Item 6.       Exhibits and Reports on Form 8-K.

         (a)      Exhibits.

Exhibit
  No.                                            Description
-------                                          -----------
3.1                         Articles  of   Incorporation,   together   with  all
                            amendments   thereto.    (Incorporated   herein   by
                            reference  to  Exhibit  2.01 of the  Company's  Form
                            10-SB filed as of November 30, 1999.)

3.2                         Bylaws.   (Incorporated   herein  by   reference  to
                            Exhibit  2.02 of the  Company's  Form 10-SB filed as
                            of November 30, 1999.)
<PAGE>

4.1                         Form of  Debenture  Purchase  Agreement by and among
                            the  Company and  purchasers  of the  Company's  12%
                            Convertible   Subordinated   Debentures   due  2002.
                            (Incorporated  herein by  reference  to Exhibit 3.01
                            to the  Company's  Form 10-SB  filed as of  November
                            30, 1999.)

4.2                         Form of 12% Convertible  Subordinated  Debenture Due
                            2002.  (Incorporated  herein by reference to Exhibit
                            3.02  to  the  Company's  Form  10-SB  filed  as  of
                            November 30, 1999.)

4.3                         Registration Rights Agreement,  dated as of December
                            31, 1997,  between the Company and Hutchison & Mason
                            PLLC.  (Incorporated  herein by reference to Exhibit
                            3.04  to  the  Company's  Form  10-SB  filed  as  of
                            November 30, 1999.)

4.4                         Stock  Purchase  Agreement,  dated as of  August  1,
                            1997,  by  and  among  the  Company,  Li-Pei  Wu and
                            William  F.  Lane (as agent  for  certain  sellers),
                            together with Addendum to Stock  Purchase  Agreement
                            of even  date  therewith.  (Incorporated  herein  by
                            reference  to  Exhibit  3.04 to the  Company's  Form
                            10-SB filed as of November 30, 1999.)

4.5                         Convertible  Debenture,  dated  September 24,  1999,
                            made by the Company in favor of  Centennial  Venture
                            Partners,  LLC  ("CVP").   (Incorporated  herein  by
                            reference  to  Exhibit  3.05 to the  Company's  Form
                            10-SB filed as of November 30, 1999.)
4.6                         Common Stock Purchase  Warrant,  dated September 24,
                            1999,  made by the Company in favor of CVP  (450,000
                            shares).   (Incorporated   herein  by  reference  to
                            Exhibit  3.06 to the  Company's  Form 10-SB filed as
                            of November 30, 1999.)
<PAGE>

4.7                         Common Stock Purchase  Warrant,  dated September 24,
                            1999,  made by the Company in favor of CVP  (150,000
                            shares).   (Incorporated   herein  by  reference  to
                            Exhibit  3.07 to the  Company's  Form 10-SB filed as
                            of November 30, 1999.)

4.8                         Common Stock Purchase  Warrant,  dated September 24,
                            1999,  made by the Company in favor of CVP  (200,000
                            shares).   (Incorporated   herein  by  reference  to
                            Exhibit  3.08 to the  Company's  Form 10-SB filed as
                            of November 30, 1999.)

4.9                         Common Stock Purchase  Warrant,  dated September 24,
                            1999,  made by the  Company  in  favor of CVP (up to
                            $500,000).  (Incorporated  herein  by  reference  to
                            Exhibit  3.09 to the  Company's  Form 10-SB filed as
                            of November 30, 1999.)

4.10                        Investor  Rights  Agreement,  dated as of  September
                            24,  1999,  by and among  the  Company  and  certain
                            holders of its capital stock.  (Incorporated  herein
                            by reference to Exhibit 3.10 to the  Company's  Form
                            10-SB filed as of November 30, 1999.)

4.11                        Shareholders  Agreement,  dated  September 24, 1999,
                            by and among the Company  and  certain  shareholders
                            and  investors.  (Incorporated  herein by  reference
                            to Exhibit  3.11 to the  Company's  Form 10-SB filed
                            as of November 30, 1999.)

27                          Financial Data Schedule.




(b)      Reports on Form 8-K.

         None



<PAGE>




                                   SIGNATURES

         In accordance with the requirements of the Exchange Act, the registrant
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

                                       ID TECHNOLOGIES CORPORATION


                               BY       /S/ J. Phillips L. Johnston
                                      ------------------------------------------
DATE:    August 9, 2000               J. Phillips L. Johnston, President and CEO


                                       /S/ William F. Lane
                                      ------------------------------------------
DATE:    August 9, 2000               William F. Lane, Chairman and Treasurer
                                           (Principal Financial Officer)